Clinical Trial

Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.

Name: Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab. — clinical trial record (NCT07564895)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Relationships of B-cell Activating Factor Gene Polymorphisms With ulcerative colitis.

Trial Details

NCT Number	NCT07564895
Lead Sponsor	Second Affiliated Hospital of Wenzhou Medical University
Conditions	Ulcerative Colitis (UC)
Enrollment	841 participants
Start Date	2018-03-01
Primary Completion	2025-06-30 (estimated)
Study Completion	2025-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-04